ORT B — Ortoma AB Share Price
Last trade - 00:00- SEK356.75m
- SEK305.31m
- SEK38.14m
- 39
- 14
- 54
- 25
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 120.66 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.06 | ||
| Price to Tang. Book | 8.76 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 9.35 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -12.67% | ||
| Return on Equity | -15.2% | ||
| Operating Margin | -57.64% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | 38.14 | 88 | 59 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ortoma AB is a Sweden-based company engaged in the medical technology. It develops an operation system for planning and positioning of joint implants in hip, knee and back surgery. The Company’s portfolio of products include Ortoma Treatment Solution, an integrated planning and measuring system, including a camera, navigation equipment and three-dimensional (3D) graphics for planning and performing prosthetic operations; Ortoma Plan, a preoperative planning system which allows surgeons to measure patient’s anatomy based on computer tomography or magnetic resonance, view it in 3D and plan operation and choice of implant before surgery; and Ortoma Guide, a navigation device which allows precise measurement and positioning of implants during operations. The Company cooperates with orthopedic departments at Sahlgrenska University Hospital, Skane University Hospital and Gothenburg University.
Directors
- Gunnar Nemeth CHM (67)
- Linus Bystrom CEO (45)
- Andreas Wolfgang CTO (42)
- Tommy Hansson OTH (76)
- Andreas Pettersson OTH (46)
- Matts Andersson DRC (71)
- Roy Forslund DRC (52)
- Peter Moller DRC (62)
- Jonny Nordqvist DRC (61)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 8th, 2001
- Public Since
- March 31st, 2014
- No. of Employees
- 3
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 37,083,731
- Address
- Falkenbergsgatan 3 8Tr, GOETEBORG, 41285
- Web
- https://ortoma.com/
- Phone
- +46 317735163
- Auditors
- Mazars SET Revisionsbyra AB
Upcoming Events for ORT B
Similar to ORT B
Acarix AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Aegirbio AB
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:16 UTC, shares in Ortoma AB are trading at SEK9.62. This share price information is delayed by 15 minutes.
Shares in Ortoma AB last closed at SEK9.62 and the price had moved by +35.49% over the past 365 days. In terms of relative price strength the Ortoma AB share price has outperformed the FTSE Global All Cap Index by +24.12% over the past year.
There is no consensus recommendation for this security.
Ortoma AB does not currently pay a dividend.
Ortoma AB does not currently pay a dividend.
Ortoma AB does not currently pay a dividend.
To buy shares in Ortoma AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK9.62, shares in Ortoma AB had a market capitalisation of SEK356.75m.
Here are the trading details for Ortoma AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: ORT B
Based on an overall assessment of its quality, value and momentum Ortoma AB is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Ortoma AB is SEK18.00. That is 87.11% above the last closing price of SEK9.62.
Analysts covering Ortoma AB currently have a consensus Earnings Per Share (EPS) forecast of SEK0.50 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ortoma AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -31.6%.
As of the last closing price of SEK9.62, shares in Ortoma AB were trading -5.44% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ortoma AB PE ratio based on its reported earnings over the past 12 months is 120.66. The shares last closed at SEK9.62.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ortoma AB's management team is headed by:
- Gunnar Nemeth - CHM
- Linus Bystrom - CEO
- Andreas Wolfgang - CTO
- Tommy Hansson - OTH
- Andreas Pettersson - OTH
- Matts Andersson - DRC
- Roy Forslund - DRC
- Peter Moller - DRC
- Jonny Nordqvist - DRC